Journal of Gynecologic Oncology

ISSN
P 2005-0380 E 2005-0399
출판사
대한부인종양학회 Korean Society of Gynecologic Oncology
국가
SOUTH KOREA
발행 상태
활성

데이터베이스 수록 정보

EMBASE 2016-2020 (5년)
JCR 2011-2019 (9년)
KCI 2009-2019 (11년)
KCI 등재 2012-2021 (10년)
KCI 등재후보 2005-2011 (7년)
MEDLINE 2016-2021 (6년)
SCIE 2010-2021 (12년)
Scopus 2017-2020 (4년)
SJR 2010-2019 (10년)

전체 12건 중 1번부터 10번까지의 결과를 표시합니다.

2025
Article

Association of NAFLD polygenic risk score and colorectal cancer in a Korean population

  • 2025-12
  • Annals of Oncology
  • Oxford University Press
2024
Article

Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]

  • Kim, J. H.
  • Shin, S. J.
  • Bae, W. K.
  • Kim, S. H.
  • Kim, J. Y.
  • ... Lim, J. H.
  • 외 14명
  • 2024-09
  • Annals of Oncology
  • Oxford University Press
2023
Article

Identification of top issues and concerns of cancer patients in Korea on social media

  • Lim, J. H.
  • Kim, D.
  • Kim, I-H.
  • Park, S. E.
  • Kim, I.
  • 외 5명
  • 2023-10
  • Annals of Oncology
  • Oxford University Press
Article

Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis

  • Kim, D.
  • Lim, J. H.
  • Kim, I-H.
  • Park, S. E.
  • Kim, I.
  • 외 5명
  • 2023-10
  • Annals of Oncology
  • Oxford University Press
2022
Article

Trajectory of physical activity and breast cancer risk: Findings from a population-based cohort study in South Korea

  • Tran, T. T. P.
  • Luu, N. M.
  • Bui, T. T.
  • Han, M.
  • Lim, M. K.
  • 외 1명
  • 2022-05
  • Annals of Oncology
  • Oxford University Press
2020
Article

EMPOWER-lung 4: Phase II, randomized, open-label high dose or standard dose cemiplimab alone/plus ipilimumab in the secondline treatment of advanced non-small cell lung cancer (NSCLC)

  • Shim, B. Y.
  • Lee, S.
  • de Castro Carpeno, J.
  • Chiu, C-H.
  • Cobo, M.
  • ... Ryu, J. S.
  • 외 7명
  • 2020-09
  • Annals of Oncology
  • Oxford University Press
2019
Article

EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment

  • Su, M.
  • Chen, L.
  • Hitre, E.
  • Lee, W.
  • Bai, L.
  • ... Lee, M.
  • 외 15명
  • 2019-07
  • Annals of Oncology
  • ELSEVIER
2018
1